Public signalCompany raiseAuto-indexed · Unverified

Cardurion Pharmaceuticals, Inc. raised $260.4M

Cardurion Pharmaceuticals, Inc.· BURLINGTON, US· Biotechnology· Filed Jul 24, 2024

Cardurion Pharmaceuticals, Inc. reported raising capital. Based in BURLINGTON, MASSACHUSETTS, US. First sale reported 2024-07-10. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$260.4M
Confidence90%
Raised
$260.4M
Investors
19
Jurisdiction
DELAWARE

On the record

Location
BURLINGTON, US
Sector
Biotechnology
Record type
Company raise
Stage
Reported raised
Amount raised
$260.4M
Target amount
$260.4M
Filing date
Jul 24, 2024
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Industry group
Biotechnology
Number of investors
19
Includes non-accredited investors
No
Revenue range
Decline to Disclose
Total offering amount
$260.4M
Amendment
No

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 260,410,720 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Jul 24, 2024. Details beyond the filing have not been verified.

Tags

USCompanyBiotechnologyOver $100MCompany Raise

Are you associated with Cardurion Pharmaceuticals, Inc.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record